“Right to Try” laws aim to boost access to unapproved therapies, but hurdles and safety concerns linger.
Source link
Longevity Firms Push Montana to Become Hub for Biohacking, Experimental Treatments
Related Posts
4 AI-Driven Outcomes Could Define the Future of Humanity
Synthetic intelligence is accelerating towards a turning level, and 4 doable outcomes — from adversarial battle to human-AI synergy —…
Tech megacaps lose $770 billion in value as Nasdaq suffers steepest drop since April
Nvidia dropped virtually 5%, pacing a steep decline in tech shares, after President Trump threatened extra tariffs on China. Source…
China’s Moonshot AI Raising Fresh Funds That Could Value It at About $4 Billion
The Beijing-based AI start-up is in talks with world traders, together with funding agency IDG Capital, for the fundraise, which…